U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H22ClN3O3
Molecular Weight 327.806
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-DESETHYL BATANOPRIDE

SMILES

CCNCCNC(=O)C1=C(OC(C)C(C)=O)C=C(N)C(Cl)=C1

InChI

InChIKey=ZRUMCJHVXNLVLW-UHFFFAOYSA-N
InChI=1S/C15H22ClN3O3/c1-4-18-5-6-19-15(21)11-7-12(16)13(17)8-14(11)22-10(3)9(2)20/h7-8,10,18H,4-6,17H2,1-3H3,(H,19,21)

HIDE SMILES / InChI

Molecular Formula C15H22ClN3O3
Molecular Weight 327.806
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:33:47 UTC 2023
Edited
by admin
on Sat Dec 16 11:33:47 UTC 2023
Record UNII
AK0HP8U7FO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-DESETHYL BATANOPRIDE
Common Name English
N-DESETHYL BATANOPRIDE METABOLITE
Common Name English
BMY-33004
Code English
Code System Code Type Description
PUBCHEM
101658374
Created by admin on Sat Dec 16 11:33:48 UTC 2023 , Edited by admin on Sat Dec 16 11:33:48 UTC 2023
PRIMARY
FDA UNII
AK0HP8U7FO
Created by admin on Sat Dec 16 11:33:48 UTC 2023 , Edited by admin on Sat Dec 16 11:33:48 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
longer elimination half-life of the three metabolites versus the parent compound in subjects with normal renal function, the disposition of the metabolites of batanopride appears to be elimination-rate limited. All three metabolites had increased AUC and half-life and reduced renal clearance as renal function worsened
MAJOR
PLASMA